174 related articles for article (PubMed ID: 24682830)
1. Neuregulin-1 signaling in the pathogenesis of chemotherapy-induced heart failure.
Lenneman CG
Curr Heart Fail Rep; 2014 Jun; 11(2):134-8. PubMed ID: 24682830
[TBL] [Abstract][Full Text] [Related]
2. Neuregulin as a heart failure therapy and mediator of reverse remodeling.
Galindo CL; Ryzhov S; Sawyer DB
Curr Heart Fail Rep; 2014 Mar; 11(1):40-9. PubMed ID: 24234399
[TBL] [Abstract][Full Text] [Related]
3. Neuregulin-1/ErbB signaling and chronic heart failure.
Xu Y; Li X; Liu X; Zhou M
Adv Pharmacol; 2010; 59():31-51. PubMed ID: 20933198
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of neuregulin-1 in cardiovascular disease.
Mendes-Ferreira P; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
Drug Discov Today; 2013 Sep; 18(17-18):836-42. PubMed ID: 23384772
[TBL] [Abstract][Full Text] [Related]
5. Role of neuregulin-1/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure.
Lemmens K; Doggen K; De Keulenaer GW
Circulation; 2007 Aug; 116(8):954-60. PubMed ID: 17709650
[TBL] [Abstract][Full Text] [Related]
6. Neuregulin in heart failure : reverse translation from cancer cardiotoxicity to new heart failure therapy.
Geisberg CA; Lenihan DJ
Herz; 2011 Jun; 36(4):306-10. PubMed ID: 21633805
[TBL] [Abstract][Full Text] [Related]
7. Central neuregulin-1/ErbB signaling modulates cardiac function via sympathetic activity in pressure overload-induced heart failure.
Matsukawa R; Hirooka Y; Ito K; Honda N; Sunagawa K
J Hypertens; 2014 Apr; 32(4):817-25. PubMed ID: 24406781
[TBL] [Abstract][Full Text] [Related]
8. Neuregulin in cardiovascular development and disease.
Odiete O; Hill MF; Sawyer DB
Circ Res; 2012 Oct; 111(10):1376-85. PubMed ID: 23104879
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of the Multitasking Endothelial Protein NRG-1 as a Compensatory Factor During Chronic Heart Failure.
De Keulenaer GW; Feyen E; Dugaucquier L; Shakeri H; Shchendrygina A; Belenkov YN; Brink M; Vermeulen Z; Segers VFM
Circ Heart Fail; 2019 Oct; 12(10):e006288. PubMed ID: 31607147
[TBL] [Abstract][Full Text] [Related]
10. Neuregulin-1/ErbB signaling: a druggable target for treating heart failure.
Xu Y; Li X; Zhou M
Curr Opin Pharmacol; 2009 Apr; 9(2):214-9. PubMed ID: 19070544
[TBL] [Abstract][Full Text] [Related]
11. Neuregulin-1 and its potential role in the control of cardiac function.
Lemmens K; Doggen K; Keulenaer GW
Heart Fail Monit; 2008 Feb; 5(4):119-24. PubMed ID: 18273495
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Potential of Neuregulin in Cardiovascular System: Can we Ignore the Effects of Neuregulin on Electrophysiology?
Wang X; Liu Z; Duan HN; Wang L
Mini Rev Med Chem; 2016; 16(11):867-71. PubMed ID: 26902151
[TBL] [Abstract][Full Text] [Related]
13. Neuregulin signaling and heart failure.
Jiang Z; Zhou M
Curr Heart Fail Rep; 2010 Mar; 7(1):42-7. PubMed ID: 20425496
[TBL] [Abstract][Full Text] [Related]
14. Circulating neuregulin during the transition from stage A to stage B/C heart failure in a breast cancer cohort.
Geisberg CA; Abdallah WM; da Silva M; Silverstein C; Smith HM; Abramson V; Mayer I; Means-Powell J; Freehardt D; White B; Lenihan D; Sawyer DB
J Card Fail; 2013 Jan; 19(1):10-5. PubMed ID: 23273589
[TBL] [Abstract][Full Text] [Related]
15. Neuregulin1 as novel therapy for heart failure.
Yan X; Morgan JP
Curr Pharm Des; 2011; 17(18):1808-17. PubMed ID: 21631420
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors.
Maurea N; Coppola C; Piscopo G; Galletta F; Riccio G; Esposito E; De Lorenzo C; De Laurentiis M; Spallarossa P; Mercuro G
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e19-e26. PubMed ID: 27755239
[TBL] [Abstract][Full Text] [Related]
17. Chronic Neuregulin-1β Treatment Mitigates the Progression of Postmyocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis, and Key Oxidant-Producing Enzymes.
Gupte M; Lal H; Ahmad F; Sawyer DB; Hill MF
J Card Fail; 2017 Dec; 23(12):887-899. PubMed ID: 28870731
[TBL] [Abstract][Full Text] [Related]
18. Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line.
Frohnert PW; Stonecypher MS; Carroll SL
Glia; 2003 Aug; 43(2):104-18. PubMed ID: 12838503
[TBL] [Abstract][Full Text] [Related]
19. The role of Neuregulin-1beta/ErbB signaling in the heart.
Pentassuglia L; Sawyer DB
Exp Cell Res; 2009 Feb; 315(4):627-37. PubMed ID: 18801360
[TBL] [Abstract][Full Text] [Related]
20. The protective role of neuregulin-1: A potential therapy for sepsis-induced cardiomyopathy.
Zhou Q; Pan X; Wang L; Wang X; Xiong D
Eur J Pharmacol; 2016 Oct; 788():234-240. PubMed ID: 27346832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
